Disparities in direct acting antivirals uptake in HIV‐hepatitis C co‐infected populations in Canada


BACKGROUND Direct acting antivirals (DAAs) have revolutionized hepatitis C (HCV) treatment with >90% cure rates even in real-world studies, giving hope that HCV can be eliminated. However, for DAAs to have a population-level impact on the burden of HCV disease, treatment uptake needs to be expanded. We investigated temporal trends in HCV treatment uptake… (More)
DOI: 10.1002/jia2.25013


5 Figures and Tables